Suchergebnisse - "Omalizumab"

PubPharm (4.145)

91

Can dose reduction be made in patients with allergic bronchopulmonary aspergillosis receiving high-dose omalizumab treatment?

enthalten in: European annals of allergy and clinical immunology | 2024

von Korkmaz, E. | Aydın, O. | Mungan, D. | +3

92

Comparison of the General Characteristics of Patients with Severe Asthma Who Switched from Omalizumab to Mepolizumab versus Patients Who Responded to Omalizumab Treatment : A Real-Life Study

enthalten in: International archives of allergy and immunology | 2024

von Cakmak, M. | Öztop, N. | Yeğit, O.

93

Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients

enthalten in: Archivos de bronconeumologia | 2024

von Valverde-Monge, M. | Sánchez-Carrasco, P. | Betancor, D. | +23

94

Comparison of the therapeutic effects of medication therapy, specific immunotherapy and anti-IgE (Omalizumab) in patients with hay fever

enthalten in: Frontiers in immunology | 2024

von Tang, R. | Lyu, X. | Hou, Y. | +6

95

Charge variants of proposed biosimilar to Omalizumab : Isolation, purification and analysis by HPLC methods

enthalten in: Annales pharmaceutiques francaises | 2024

von Gupta, T. | Seshadri, S.

96

Retrospective analysis of laboratory results in 18 cases of severe asthma treated with omalizumab

enthalten in: American journal of clinical and experimental immunology | 2024

von Li, W. | Ge, Y. | Qu, X. | +6

97

Comparative efficacy of ligelizumab versus omalizumab in chronic spontaneous urticaria

enthalten in: Lancet (London, England) | 2024

von Moussa, S. | Netchiporouk, E.

98

Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria : results of two phase 3 randomised controlled trials

enthalten in: Lancet (London, England) | 2024

von Maurer, M. | Ensina, L. | Gimenez-Arnau, A. | +134

99

Use of omalizumab is associated with improvement of pruritic skin disorders induced by immune checkpoint inhibitors : A retrospective cohort from the European Task Force of Dermatology for Cancer patients

enthalten in: Journal of the American Academy of Dermatology | 2024

von Alamon-Reig, F. | Bosch-Amate, X. | Giavedoni, P. | +8

100

Evaluation of Pediatric Chronic Urticaria with Emphasis on Clinical and Laboratory Characteristics and Treatment Response to Omalizumab : A Real-Life Experience from a Tertiary Allergy Center

enthalten in: Children (Basel, Switzerland) | 2024

von Özhan, A. | Arıkoğlu, T.